NCT03831620View on ClinicalTrials.gov

The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary Hyperparathyroidism

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Primary Hyperparathyroidism
Trial Locations (1)

3010

Department of visceral surgery and transplant surgery, Berne University Hospital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03831620 - The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter